The rating agency believes that given its soft operating performance, Glenmark will have to implement strategic measures – such as the monetisation of its active pharmaceutical ingredient business or the NCE portfolio – to substantially bring down its leverage.
from The Financial ExpressThe Financial Express https://ift.tt/30aM8Ky
No comments:
Post a Comment